Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
7,533
archived clinical trials in
Chronic Obstructive Pulmonary Disease

Long-term Oxygen Treatment Trial
Effectiveness of Long-term Oxygen Therapy in Treating People With Chronic Obstructive Pulmonary Disease
Status: Enrolling
Updated:  10/6/2015
Cleveland Clinic Foundation
mi
from
Cleveland, OH
Long-term Oxygen Treatment Trial
Effectiveness of Long-term Oxygen Therapy in Treating People With Chronic Obstructive Pulmonary Disease
Status: Enrolling
Updated: 10/6/2015
Cleveland Clinic Foundation
mi
from
Cleveland, OH
Click here to add this to my saved trials
Long-term Oxygen Treatment Trial
Effectiveness of Long-term Oxygen Therapy in Treating People With Chronic Obstructive Pulmonary Disease
Status: Enrolling
Updated:  10/6/2015
Ohio State University
mi
from
Columbus, OH
Long-term Oxygen Treatment Trial
Effectiveness of Long-term Oxygen Therapy in Treating People With Chronic Obstructive Pulmonary Disease
Status: Enrolling
Updated: 10/6/2015
Ohio State University
mi
from
Columbus, OH
Click here to add this to my saved trials
Long-term Oxygen Treatment Trial
Effectiveness of Long-term Oxygen Therapy in Treating People With Chronic Obstructive Pulmonary Disease
Status: Enrolling
Updated:  10/6/2015
Kaiser Foundation Hospitals
mi
from
Portland, OR
Long-term Oxygen Treatment Trial
Effectiveness of Long-term Oxygen Therapy in Treating People With Chronic Obstructive Pulmonary Disease
Status: Enrolling
Updated: 10/6/2015
Kaiser Foundation Hospitals
mi
from
Portland, OR
Click here to add this to my saved trials
Long-term Oxygen Treatment Trial
Effectiveness of Long-term Oxygen Therapy in Treating People With Chronic Obstructive Pulmonary Disease
Status: Enrolling
Updated:  10/6/2015
Geisinger Institute
mi
from
Danville, PA
Long-term Oxygen Treatment Trial
Effectiveness of Long-term Oxygen Therapy in Treating People With Chronic Obstructive Pulmonary Disease
Status: Enrolling
Updated: 10/6/2015
Geisinger Institute
mi
from
Danville, PA
Click here to add this to my saved trials
Long-term Oxygen Treatment Trial
Effectiveness of Long-term Oxygen Therapy in Treating People With Chronic Obstructive Pulmonary Disease
Status: Enrolling
Updated:  10/6/2015
Institute for Respiratory and Sleep Medicine
mi
from
Langhorne, PA
Long-term Oxygen Treatment Trial
Effectiveness of Long-term Oxygen Therapy in Treating People With Chronic Obstructive Pulmonary Disease
Status: Enrolling
Updated: 10/6/2015
Institute for Respiratory and Sleep Medicine
mi
from
Langhorne, PA
Click here to add this to my saved trials
Long-term Oxygen Treatment Trial
Effectiveness of Long-term Oxygen Therapy in Treating People With Chronic Obstructive Pulmonary Disease
Status: Enrolling
Updated:  10/6/2015
Temple University
mi
from
Philadelphia, PA
Long-term Oxygen Treatment Trial
Effectiveness of Long-term Oxygen Therapy in Treating People With Chronic Obstructive Pulmonary Disease
Status: Enrolling
Updated: 10/6/2015
Temple University
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Long-term Oxygen Treatment Trial
Effectiveness of Long-term Oxygen Therapy in Treating People With Chronic Obstructive Pulmonary Disease
Status: Enrolling
Updated:  10/6/2015
University of Pittsburgh
mi
from
Pittsburgh, PA
Long-term Oxygen Treatment Trial
Effectiveness of Long-term Oxygen Therapy in Treating People With Chronic Obstructive Pulmonary Disease
Status: Enrolling
Updated: 10/6/2015
University of Pittsburgh
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Long-term Oxygen Treatment Trial
Effectiveness of Long-term Oxygen Therapy in Treating People With Chronic Obstructive Pulmonary Disease
Status: Enrolling
Updated:  10/6/2015
University of Texas, San Antonio
mi
from
San Antonio, TX
Long-term Oxygen Treatment Trial
Effectiveness of Long-term Oxygen Therapy in Treating People With Chronic Obstructive Pulmonary Disease
Status: Enrolling
Updated: 10/6/2015
University of Texas, San Antonio
mi
from
San Antonio, TX
Click here to add this to my saved trials
Long-term Oxygen Treatment Trial
Effectiveness of Long-term Oxygen Therapy in Treating People With Chronic Obstructive Pulmonary Disease
Status: Enrolling
Updated:  10/6/2015
University of Utah
mi
from
Salt Lake City, UT
Long-term Oxygen Treatment Trial
Effectiveness of Long-term Oxygen Therapy in Treating People With Chronic Obstructive Pulmonary Disease
Status: Enrolling
Updated: 10/6/2015
University of Utah
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Long-term Oxygen Treatment Trial
Effectiveness of Long-term Oxygen Therapy in Treating People With Chronic Obstructive Pulmonary Disease
Status: Enrolling
Updated:  10/6/2015
Univ of Washington
mi
from
Seattle, WA
Long-term Oxygen Treatment Trial
Effectiveness of Long-term Oxygen Therapy in Treating People With Chronic Obstructive Pulmonary Disease
Status: Enrolling
Updated: 10/6/2015
Univ of Washington
mi
from
Seattle, WA
Click here to add this to my saved trials
Long-term Oxygen Treatment Trial
Effectiveness of Long-term Oxygen Therapy in Treating People With Chronic Obstructive Pulmonary Disease
Status: Enrolling
Updated:  10/6/2015
Puget Sound VA Medical Center
mi
from
Seattle, WA
Long-term Oxygen Treatment Trial
Effectiveness of Long-term Oxygen Therapy in Treating People With Chronic Obstructive Pulmonary Disease
Status: Enrolling
Updated: 10/6/2015
Puget Sound VA Medical Center
mi
from
Seattle, WA
Click here to add this to my saved trials
Long-term Oxygen Treatment Trial
Effectiveness of Long-term Oxygen Therapy in Treating People With Chronic Obstructive Pulmonary Disease
Status: Enrolling
Updated:  10/6/2015
Harborview Medical Center
mi
from
Seattle, WA
Long-term Oxygen Treatment Trial
Effectiveness of Long-term Oxygen Therapy in Treating People With Chronic Obstructive Pulmonary Disease
Status: Enrolling
Updated: 10/6/2015
Harborview Medical Center
mi
from
Seattle, WA
Click here to add this to my saved trials
Long-term Oxygen Treatment Trial
Effectiveness of Long-term Oxygen Therapy in Treating People With Chronic Obstructive Pulmonary Disease
Status: Enrolling
Updated:  10/6/2015
University of Alabama
mi
from
Birmingham, AL
Long-term Oxygen Treatment Trial
Effectiveness of Long-term Oxygen Therapy in Treating People With Chronic Obstructive Pulmonary Disease
Status: Enrolling
Updated: 10/6/2015
University of Alabama
mi
from
Birmingham, AL
Click here to add this to my saved trials
Long-term Oxygen Treatment Trial
Effectiveness of Long-term Oxygen Therapy in Treating People With Chronic Obstructive Pulmonary Disease
Status: Enrolling
Updated:  10/6/2015
Boston Med Ctr
mi
from
Boston, MA
Long-term Oxygen Treatment Trial
Effectiveness of Long-term Oxygen Therapy in Treating People With Chronic Obstructive Pulmonary Disease
Status: Enrolling
Updated: 10/6/2015
Boston Med Ctr
mi
from
Boston, MA
Click here to add this to my saved trials
Long-term Oxygen Treatment Trial
Effectiveness of Long-term Oxygen Therapy in Treating People With Chronic Obstructive Pulmonary Disease
Status: Enrolling
Updated:  10/6/2015
Respiratory Specialists
mi
from
Wyomissing, PA
Long-term Oxygen Treatment Trial
Effectiveness of Long-term Oxygen Therapy in Treating People With Chronic Obstructive Pulmonary Disease
Status: Enrolling
Updated: 10/6/2015
Respiratory Specialists
mi
from
Wyomissing, PA
Click here to add this to my saved trials
The Effect of OMT on Patients With COPD: Correlating Pulmonary Function Tests With Biochemical Alterations
The Effect of Osteopathic Manipulative Treatment on Patients With Chronic Obstructive Pulmonary Disease:Correlating Pulmonary Function Tests With Biochemical Alterations
Status: Enrolling
Updated:  10/6/2015
McClaren-Greater Lansing
mi
from
Lansing, MI
The Effect of OMT on Patients With COPD: Correlating Pulmonary Function Tests With Biochemical Alterations
The Effect of Osteopathic Manipulative Treatment on Patients With Chronic Obstructive Pulmonary Disease:Correlating Pulmonary Function Tests With Biochemical Alterations
Status: Enrolling
Updated: 10/6/2015
McClaren-Greater Lansing
mi
from
Lansing, MI
Click here to add this to my saved trials
Effects of Ventavis in Patients With Pulmonary Hypertension (PH) Secondary to Chronic Obstructive Pulmonary Disease (COPD)
A Phase 2, Multi-center, Double-blind, Randomized, Placebo-controlled Study to Evaluate the Effects of Inhaled Iloprost on Endurance Time During Cardiopulmonary Exercise Testing in Patients With Pulmonary Hypertension Secondary to Chronic Obstructive Pulmonary Disease
Status: Enrolling
Updated:  10/16/2015
Los Angeles Biomedical Research Institute
mi
from
Torrance, CA
Effects of Ventavis in Patients With Pulmonary Hypertension (PH) Secondary to Chronic Obstructive Pulmonary Disease (COPD)
A Phase 2, Multi-center, Double-blind, Randomized, Placebo-controlled Study to Evaluate the Effects of Inhaled Iloprost on Endurance Time During Cardiopulmonary Exercise Testing in Patients With Pulmonary Hypertension Secondary to Chronic Obstructive Pulmonary Disease
Status: Enrolling
Updated: 10/16/2015
Los Angeles Biomedical Research Institute
mi
from
Torrance, CA
Click here to add this to my saved trials
Effects of Ventavis in Patients With Pulmonary Hypertension (PH) Secondary to Chronic Obstructive Pulmonary Disease (COPD)
A Phase 2, Multi-center, Double-blind, Randomized, Placebo-controlled Study to Evaluate the Effects of Inhaled Iloprost on Endurance Time During Cardiopulmonary Exercise Testing in Patients With Pulmonary Hypertension Secondary to Chronic Obstructive Pulmonary Disease
Status: Enrolling
Updated:  10/16/2015
Massachusetts General Hospital
mi
from
Boston, MA
Effects of Ventavis in Patients With Pulmonary Hypertension (PH) Secondary to Chronic Obstructive Pulmonary Disease (COPD)
A Phase 2, Multi-center, Double-blind, Randomized, Placebo-controlled Study to Evaluate the Effects of Inhaled Iloprost on Endurance Time During Cardiopulmonary Exercise Testing in Patients With Pulmonary Hypertension Secondary to Chronic Obstructive Pulmonary Disease
Status: Enrolling
Updated: 10/16/2015
Massachusetts General Hospital
mi
from
Boston, MA
Click here to add this to my saved trials
Effects of Ventavis in Patients With Pulmonary Hypertension (PH) Secondary to Chronic Obstructive Pulmonary Disease (COPD)
A Phase 2, Multi-center, Double-blind, Randomized, Placebo-controlled Study to Evaluate the Effects of Inhaled Iloprost on Endurance Time During Cardiopulmonary Exercise Testing in Patients With Pulmonary Hypertension Secondary to Chronic Obstructive Pulmonary Disease
Status: Enrolling
Updated:  10/16/2015
Cleveland Clinic
mi
from
Cleveland, OH
Effects of Ventavis in Patients With Pulmonary Hypertension (PH) Secondary to Chronic Obstructive Pulmonary Disease (COPD)
A Phase 2, Multi-center, Double-blind, Randomized, Placebo-controlled Study to Evaluate the Effects of Inhaled Iloprost on Endurance Time During Cardiopulmonary Exercise Testing in Patients With Pulmonary Hypertension Secondary to Chronic Obstructive Pulmonary Disease
Status: Enrolling
Updated: 10/16/2015
Cleveland Clinic
mi
from
Cleveland, OH
Click here to add this to my saved trials
Effects of Ventavis in Patients With Pulmonary Hypertension (PH) Secondary to Chronic Obstructive Pulmonary Disease (COPD)
A Phase 2, Multi-center, Double-blind, Randomized, Placebo-controlled Study to Evaluate the Effects of Inhaled Iloprost on Endurance Time During Cardiopulmonary Exercise Testing in Patients With Pulmonary Hypertension Secondary to Chronic Obstructive Pulmonary Disease
Status: Enrolling
Updated:  10/16/2015
University of Oklahoma Health Sciences Center
mi
from
Oklahoma City, OK
Effects of Ventavis in Patients With Pulmonary Hypertension (PH) Secondary to Chronic Obstructive Pulmonary Disease (COPD)
A Phase 2, Multi-center, Double-blind, Randomized, Placebo-controlled Study to Evaluate the Effects of Inhaled Iloprost on Endurance Time During Cardiopulmonary Exercise Testing in Patients With Pulmonary Hypertension Secondary to Chronic Obstructive Pulmonary Disease
Status: Enrolling
Updated: 10/16/2015
University of Oklahoma Health Sciences Center
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
Effects of Ventavis in Patients With Pulmonary Hypertension (PH) Secondary to Chronic Obstructive Pulmonary Disease (COPD)
A Phase 2, Multi-center, Double-blind, Randomized, Placebo-controlled Study to Evaluate the Effects of Inhaled Iloprost on Endurance Time During Cardiopulmonary Exercise Testing in Patients With Pulmonary Hypertension Secondary to Chronic Obstructive Pulmonary Disease
Status: Enrolling
Updated:  10/16/2015
Temple University Hospital
mi
from
Philadelphia, PA
Effects of Ventavis in Patients With Pulmonary Hypertension (PH) Secondary to Chronic Obstructive Pulmonary Disease (COPD)
A Phase 2, Multi-center, Double-blind, Randomized, Placebo-controlled Study to Evaluate the Effects of Inhaled Iloprost on Endurance Time During Cardiopulmonary Exercise Testing in Patients With Pulmonary Hypertension Secondary to Chronic Obstructive Pulmonary Disease
Status: Enrolling
Updated: 10/16/2015
Temple University Hospital
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Effects of Ventavis in Patients With Pulmonary Hypertension (PH) Secondary to Chronic Obstructive Pulmonary Disease (COPD)
A Phase 2, Multi-center, Double-blind, Randomized, Placebo-controlled Study to Evaluate the Effects of Inhaled Iloprost on Endurance Time During Cardiopulmonary Exercise Testing in Patients With Pulmonary Hypertension Secondary to Chronic Obstructive Pulmonary Disease
Status: Enrolling
Updated:  10/16/2015
University of Pittsburgh Medical Center
mi
from
Pittsburgh, PA
Effects of Ventavis in Patients With Pulmonary Hypertension (PH) Secondary to Chronic Obstructive Pulmonary Disease (COPD)
A Phase 2, Multi-center, Double-blind, Randomized, Placebo-controlled Study to Evaluate the Effects of Inhaled Iloprost on Endurance Time During Cardiopulmonary Exercise Testing in Patients With Pulmonary Hypertension Secondary to Chronic Obstructive Pulmonary Disease
Status: Enrolling
Updated: 10/16/2015
University of Pittsburgh Medical Center
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Effects of Ventavis in Patients With Pulmonary Hypertension (PH) Secondary to Chronic Obstructive Pulmonary Disease (COPD)
A Phase 2, Multi-center, Double-blind, Randomized, Placebo-controlled Study to Evaluate the Effects of Inhaled Iloprost on Endurance Time During Cardiopulmonary Exercise Testing in Patients With Pulmonary Hypertension Secondary to Chronic Obstructive Pulmonary Disease
Status: Enrolling
Updated:  10/16/2015
Mayo Clinic, Jacksonville
mi
from
Jacksonville, FL
Effects of Ventavis in Patients With Pulmonary Hypertension (PH) Secondary to Chronic Obstructive Pulmonary Disease (COPD)
A Phase 2, Multi-center, Double-blind, Randomized, Placebo-controlled Study to Evaluate the Effects of Inhaled Iloprost on Endurance Time During Cardiopulmonary Exercise Testing in Patients With Pulmonary Hypertension Secondary to Chronic Obstructive Pulmonary Disease
Status: Enrolling
Updated: 10/16/2015
Mayo Clinic, Jacksonville
mi
from
Jacksonville, FL
Click here to add this to my saved trials
Effects of Ventavis in Patients With Pulmonary Hypertension (PH) Secondary to Chronic Obstructive Pulmonary Disease (COPD)
A Phase 2, Multi-center, Double-blind, Randomized, Placebo-controlled Study to Evaluate the Effects of Inhaled Iloprost on Endurance Time During Cardiopulmonary Exercise Testing in Patients With Pulmonary Hypertension Secondary to Chronic Obstructive Pulmonary Disease
Status: Enrolling
Updated:  10/16/2015
Northwestern University
mi
from
Chicago, IL
Effects of Ventavis in Patients With Pulmonary Hypertension (PH) Secondary to Chronic Obstructive Pulmonary Disease (COPD)
A Phase 2, Multi-center, Double-blind, Randomized, Placebo-controlled Study to Evaluate the Effects of Inhaled Iloprost on Endurance Time During Cardiopulmonary Exercise Testing in Patients With Pulmonary Hypertension Secondary to Chronic Obstructive Pulmonary Disease
Status: Enrolling
Updated: 10/16/2015
Northwestern University
mi
from
Chicago, IL
Click here to add this to my saved trials
Effects of Ventavis in Patients With Pulmonary Hypertension (PH) Secondary to Chronic Obstructive Pulmonary Disease (COPD)
A Phase 2, Multi-center, Double-blind, Randomized, Placebo-controlled Study to Evaluate the Effects of Inhaled Iloprost on Endurance Time During Cardiopulmonary Exercise Testing in Patients With Pulmonary Hypertension Secondary to Chronic Obstructive Pulmonary Disease
Status: Enrolling
Updated:  10/16/2015
Ochsner Clinic Foundation
mi
from
New Orleans, LA
Effects of Ventavis in Patients With Pulmonary Hypertension (PH) Secondary to Chronic Obstructive Pulmonary Disease (COPD)
A Phase 2, Multi-center, Double-blind, Randomized, Placebo-controlled Study to Evaluate the Effects of Inhaled Iloprost on Endurance Time During Cardiopulmonary Exercise Testing in Patients With Pulmonary Hypertension Secondary to Chronic Obstructive Pulmonary Disease
Status: Enrolling
Updated: 10/16/2015
Ochsner Clinic Foundation
mi
from
New Orleans, LA
Click here to add this to my saved trials
Effects of Ventavis in Patients With Pulmonary Hypertension (PH) Secondary to Chronic Obstructive Pulmonary Disease (COPD)
A Phase 2, Multi-center, Double-blind, Randomized, Placebo-controlled Study to Evaluate the Effects of Inhaled Iloprost on Endurance Time During Cardiopulmonary Exercise Testing in Patients With Pulmonary Hypertension Secondary to Chronic Obstructive Pulmonary Disease
Status: Enrolling
Updated:  10/16/2015
Hopital d'adultes de Brabois
mi
from
Vandoeuvre-lès-Nancy,
Effects of Ventavis in Patients With Pulmonary Hypertension (PH) Secondary to Chronic Obstructive Pulmonary Disease (COPD)
A Phase 2, Multi-center, Double-blind, Randomized, Placebo-controlled Study to Evaluate the Effects of Inhaled Iloprost on Endurance Time During Cardiopulmonary Exercise Testing in Patients With Pulmonary Hypertension Secondary to Chronic Obstructive Pulmonary Disease
Status: Enrolling
Updated: 10/16/2015
Hopital d'adultes de Brabois
mi
from
Vandoeuvre-lès-Nancy,
Click here to add this to my saved trials
Outlook Quality of Life Intervention Study
Outlook: An Intervention to Improve Quality of Life in Serious Illness Study
Status: Enrolling
Updated:  10/19/2015
Durham VA Medical Center HSR&D COE
mi
from
Durham, NC
Outlook Quality of Life Intervention Study
Outlook: An Intervention to Improve Quality of Life in Serious Illness Study
Status: Enrolling
Updated: 10/19/2015
Durham VA Medical Center HSR&D COE
mi
from
Durham, NC
Click here to add this to my saved trials
SUN11031 in Cachexia Associated With Chronic Obstructive Pulmonary Disease (COPD)
A Phase 2b, Multicenter, Randomized, Double-Blind, Parallel, Placebo-Controlled Study to Evaluate the Efficacy and Safety of SUN11031 for Injection Administered Subcutaneously Twice Daily for 12 Weeks to Subjects Having Cachexia Associated With Chronic Obstructive Pulmonary Disease
Status: Enrolling
Updated:  10/19/2015
Waterbury Pulmonary Associates
mi
from
Waterbury, CT
SUN11031 in Cachexia Associated With Chronic Obstructive Pulmonary Disease (COPD)
A Phase 2b, Multicenter, Randomized, Double-Blind, Parallel, Placebo-Controlled Study to Evaluate the Efficacy and Safety of SUN11031 for Injection Administered Subcutaneously Twice Daily for 12 Weeks to Subjects Having Cachexia Associated With Chronic Obstructive Pulmonary Disease
Status: Enrolling
Updated: 10/19/2015
Waterbury Pulmonary Associates
mi
from
Waterbury, CT
Click here to add this to my saved trials
SUN11031 in Cachexia Associated With Chronic Obstructive Pulmonary Disease (COPD)
A Phase 2b, Multicenter, Randomized, Double-Blind, Parallel, Placebo-Controlled Study to Evaluate the Efficacy and Safety of SUN11031 for Injection Administered Subcutaneously Twice Daily for 12 Weeks to Subjects Having Cachexia Associated With Chronic Obstructive Pulmonary Disease
Status: Enrolling
Updated:  10/19/2015
Clinical Research of West Florida
mi
from
Clearwater, FL
SUN11031 in Cachexia Associated With Chronic Obstructive Pulmonary Disease (COPD)
A Phase 2b, Multicenter, Randomized, Double-Blind, Parallel, Placebo-Controlled Study to Evaluate the Efficacy and Safety of SUN11031 for Injection Administered Subcutaneously Twice Daily for 12 Weeks to Subjects Having Cachexia Associated With Chronic Obstructive Pulmonary Disease
Status: Enrolling
Updated: 10/19/2015
Clinical Research of West Florida
mi
from
Clearwater, FL
Click here to add this to my saved trials
SUN11031 in Cachexia Associated With Chronic Obstructive Pulmonary Disease (COPD)
A Phase 2b, Multicenter, Randomized, Double-Blind, Parallel, Placebo-Controlled Study to Evaluate the Efficacy and Safety of SUN11031 for Injection Administered Subcutaneously Twice Daily for 12 Weeks to Subjects Having Cachexia Associated With Chronic Obstructive Pulmonary Disease
Status: Enrolling
Updated:  10/19/2015
Innovative Research of West Florida
mi
from
Largo, FL
SUN11031 in Cachexia Associated With Chronic Obstructive Pulmonary Disease (COPD)
A Phase 2b, Multicenter, Randomized, Double-Blind, Parallel, Placebo-Controlled Study to Evaluate the Efficacy and Safety of SUN11031 for Injection Administered Subcutaneously Twice Daily for 12 Weeks to Subjects Having Cachexia Associated With Chronic Obstructive Pulmonary Disease
Status: Enrolling
Updated: 10/19/2015
Innovative Research of West Florida
mi
from
Largo, FL
Click here to add this to my saved trials
SUN11031 in Cachexia Associated With Chronic Obstructive Pulmonary Disease (COPD)
A Phase 2b, Multicenter, Randomized, Double-Blind, Parallel, Placebo-Controlled Study to Evaluate the Efficacy and Safety of SUN11031 for Injection Administered Subcutaneously Twice Daily for 12 Weeks to Subjects Having Cachexia Associated With Chronic Obstructive Pulmonary Disease
Status: Enrolling
Updated:  10/19/2015
The Center for Clinical Research, Washington County Hospital
mi
from
Hagerstown, MD
SUN11031 in Cachexia Associated With Chronic Obstructive Pulmonary Disease (COPD)
A Phase 2b, Multicenter, Randomized, Double-Blind, Parallel, Placebo-Controlled Study to Evaluate the Efficacy and Safety of SUN11031 for Injection Administered Subcutaneously Twice Daily for 12 Weeks to Subjects Having Cachexia Associated With Chronic Obstructive Pulmonary Disease
Status: Enrolling
Updated: 10/19/2015
The Center for Clinical Research, Washington County Hospital
mi
from
Hagerstown, MD
Click here to add this to my saved trials
SUN11031 in Cachexia Associated With Chronic Obstructive Pulmonary Disease (COPD)
A Phase 2b, Multicenter, Randomized, Double-Blind, Parallel, Placebo-Controlled Study to Evaluate the Efficacy and Safety of SUN11031 for Injection Administered Subcutaneously Twice Daily for 12 Weeks to Subjects Having Cachexia Associated With Chronic Obstructive Pulmonary Disease
Status: Enrolling
Updated:  10/19/2015
Montana Medical Research
mi
from
Missoula, MT
SUN11031 in Cachexia Associated With Chronic Obstructive Pulmonary Disease (COPD)
A Phase 2b, Multicenter, Randomized, Double-Blind, Parallel, Placebo-Controlled Study to Evaluate the Efficacy and Safety of SUN11031 for Injection Administered Subcutaneously Twice Daily for 12 Weeks to Subjects Having Cachexia Associated With Chronic Obstructive Pulmonary Disease
Status: Enrolling
Updated: 10/19/2015
Montana Medical Research
mi
from
Missoula, MT
Click here to add this to my saved trials
SUN11031 in Cachexia Associated With Chronic Obstructive Pulmonary Disease (COPD)
A Phase 2b, Multicenter, Randomized, Double-Blind, Parallel, Placebo-Controlled Study to Evaluate the Efficacy and Safety of SUN11031 for Injection Administered Subcutaneously Twice Daily for 12 Weeks to Subjects Having Cachexia Associated With Chronic Obstructive Pulmonary Disease
Status: Enrolling
Updated:  10/19/2015
The Asthma & Allergy Center, P.C.
mi
from
Papillion, NE
SUN11031 in Cachexia Associated With Chronic Obstructive Pulmonary Disease (COPD)
A Phase 2b, Multicenter, Randomized, Double-Blind, Parallel, Placebo-Controlled Study to Evaluate the Efficacy and Safety of SUN11031 for Injection Administered Subcutaneously Twice Daily for 12 Weeks to Subjects Having Cachexia Associated With Chronic Obstructive Pulmonary Disease
Status: Enrolling
Updated: 10/19/2015
The Asthma & Allergy Center, P.C.
mi
from
Papillion, NE
Click here to add this to my saved trials
SUN11031 in Cachexia Associated With Chronic Obstructive Pulmonary Disease (COPD)
A Phase 2b, Multicenter, Randomized, Double-Blind, Parallel, Placebo-Controlled Study to Evaluate the Efficacy and Safety of SUN11031 for Injection Administered Subcutaneously Twice Daily for 12 Weeks to Subjects Having Cachexia Associated With Chronic Obstructive Pulmonary Disease
Status: Enrolling
Updated:  10/19/2015
Health Science Research Center - Asthma & Allergy Associates
mi
from
Cortland, NY
SUN11031 in Cachexia Associated With Chronic Obstructive Pulmonary Disease (COPD)
A Phase 2b, Multicenter, Randomized, Double-Blind, Parallel, Placebo-Controlled Study to Evaluate the Efficacy and Safety of SUN11031 for Injection Administered Subcutaneously Twice Daily for 12 Weeks to Subjects Having Cachexia Associated With Chronic Obstructive Pulmonary Disease
Status: Enrolling
Updated: 10/19/2015
Health Science Research Center - Asthma & Allergy Associates
mi
from
Cortland, NY
Click here to add this to my saved trials
SUN11031 in Cachexia Associated With Chronic Obstructive Pulmonary Disease (COPD)
A Phase 2b, Multicenter, Randomized, Double-Blind, Parallel, Placebo-Controlled Study to Evaluate the Efficacy and Safety of SUN11031 for Injection Administered Subcutaneously Twice Daily for 12 Weeks to Subjects Having Cachexia Associated With Chronic Obstructive Pulmonary Disease
Status: Enrolling
Updated:  10/19/2015
New Horizons Clinical Research
mi
from
Cincinnati, OH
SUN11031 in Cachexia Associated With Chronic Obstructive Pulmonary Disease (COPD)
A Phase 2b, Multicenter, Randomized, Double-Blind, Parallel, Placebo-Controlled Study to Evaluate the Efficacy and Safety of SUN11031 for Injection Administered Subcutaneously Twice Daily for 12 Weeks to Subjects Having Cachexia Associated With Chronic Obstructive Pulmonary Disease
Status: Enrolling
Updated: 10/19/2015
New Horizons Clinical Research
mi
from
Cincinnati, OH
Click here to add this to my saved trials
SUN11031 in Cachexia Associated With Chronic Obstructive Pulmonary Disease (COPD)
A Phase 2b, Multicenter, Randomized, Double-Blind, Parallel, Placebo-Controlled Study to Evaluate the Efficacy and Safety of SUN11031 for Injection Administered Subcutaneously Twice Daily for 12 Weeks to Subjects Having Cachexia Associated With Chronic Obstructive Pulmonary Disease
Status: Enrolling
Updated:  10/19/2015
Clinical Research Institute of Southern Oregon, PC
mi
from
Medford, OR
SUN11031 in Cachexia Associated With Chronic Obstructive Pulmonary Disease (COPD)
A Phase 2b, Multicenter, Randomized, Double-Blind, Parallel, Placebo-Controlled Study to Evaluate the Efficacy and Safety of SUN11031 for Injection Administered Subcutaneously Twice Daily for 12 Weeks to Subjects Having Cachexia Associated With Chronic Obstructive Pulmonary Disease
Status: Enrolling
Updated: 10/19/2015
Clinical Research Institute of Southern Oregon, PC
mi
from
Medford, OR
Click here to add this to my saved trials
SUN11031 in Cachexia Associated With Chronic Obstructive Pulmonary Disease (COPD)
A Phase 2b, Multicenter, Randomized, Double-Blind, Parallel, Placebo-Controlled Study to Evaluate the Efficacy and Safety of SUN11031 for Injection Administered Subcutaneously Twice Daily for 12 Weeks to Subjects Having Cachexia Associated With Chronic Obstructive Pulmonary Disease
Status: Enrolling
Updated:  10/19/2015
Spartanburg Medical Research
mi
from
Spartanburg, SC
SUN11031 in Cachexia Associated With Chronic Obstructive Pulmonary Disease (COPD)
A Phase 2b, Multicenter, Randomized, Double-Blind, Parallel, Placebo-Controlled Study to Evaluate the Efficacy and Safety of SUN11031 for Injection Administered Subcutaneously Twice Daily for 12 Weeks to Subjects Having Cachexia Associated With Chronic Obstructive Pulmonary Disease
Status: Enrolling
Updated: 10/19/2015
Spartanburg Medical Research
mi
from
Spartanburg, SC
Click here to add this to my saved trials
SUN11031 in Cachexia Associated With Chronic Obstructive Pulmonary Disease (COPD)
A Phase 2b, Multicenter, Randomized, Double-Blind, Parallel, Placebo-Controlled Study to Evaluate the Efficacy and Safety of SUN11031 for Injection Administered Subcutaneously Twice Daily for 12 Weeks to Subjects Having Cachexia Associated With Chronic Obstructive Pulmonary Disease
Status: Enrolling
Updated:  10/19/2015
Pulmonary Consultants, Pllc
mi
from
Tacoma, WA
SUN11031 in Cachexia Associated With Chronic Obstructive Pulmonary Disease (COPD)
A Phase 2b, Multicenter, Randomized, Double-Blind, Parallel, Placebo-Controlled Study to Evaluate the Efficacy and Safety of SUN11031 for Injection Administered Subcutaneously Twice Daily for 12 Weeks to Subjects Having Cachexia Associated With Chronic Obstructive Pulmonary Disease
Status: Enrolling
Updated: 10/19/2015
Pulmonary Consultants, Pllc
mi
from
Tacoma, WA
Click here to add this to my saved trials
SUN11031 in Cachexia Associated With Chronic Obstructive Pulmonary Disease (COPD)
A Phase 2b, Multicenter, Randomized, Double-Blind, Parallel, Placebo-Controlled Study to Evaluate the Efficacy and Safety of SUN11031 for Injection Administered Subcutaneously Twice Daily for 12 Weeks to Subjects Having Cachexia Associated With Chronic Obstructive Pulmonary Disease
Status: Enrolling
Updated:  10/19/2015
Centro de Investigaciones Médicas
mi
from
Florencío Varela,
SUN11031 in Cachexia Associated With Chronic Obstructive Pulmonary Disease (COPD)
A Phase 2b, Multicenter, Randomized, Double-Blind, Parallel, Placebo-Controlled Study to Evaluate the Efficacy and Safety of SUN11031 for Injection Administered Subcutaneously Twice Daily for 12 Weeks to Subjects Having Cachexia Associated With Chronic Obstructive Pulmonary Disease
Status: Enrolling
Updated: 10/19/2015
Centro de Investigaciones Médicas
mi
from
Florencío Varela,
Click here to add this to my saved trials
Tiotropium + Olodaterol Fixed Dose Combination (FDC) in Chronic Obstructive Pulmonary Disease (OTEMTO 1)
A Randomised, Double-blind, Placebo- and Active-controlled Parallel Group Study to Assess the Efficacy of 12 Weeks of Once Daily Treatment of Two Doses of Orally Inhaled Tiotropium + Olodaterol Fixed Dose Combination (Delivered by the Respimat Inhaler) in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)
Status: Enrolling
Updated:  10/23/2015
1222.29.11012 Boehringer Ingelheim Investigational Site
mi
from
Wheat Ridge, CO
Tiotropium + Olodaterol Fixed Dose Combination (FDC) in Chronic Obstructive Pulmonary Disease (OTEMTO 1)
A Randomised, Double-blind, Placebo- and Active-controlled Parallel Group Study to Assess the Efficacy of 12 Weeks of Once Daily Treatment of Two Doses of Orally Inhaled Tiotropium + Olodaterol Fixed Dose Combination (Delivered by the Respimat Inhaler) in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)
Status: Enrolling
Updated: 10/23/2015
1222.29.11012 Boehringer Ingelheim Investigational Site
mi
from
Wheat Ridge, CO
Click here to add this to my saved trials
Tiotropium + Olodaterol Fixed Dose Combination (FDC) in Chronic Obstructive Pulmonary Disease (OTEMTO 1)
A Randomised, Double-blind, Placebo- and Active-controlled Parallel Group Study to Assess the Efficacy of 12 Weeks of Once Daily Treatment of Two Doses of Orally Inhaled Tiotropium + Olodaterol Fixed Dose Combination (Delivered by the Respimat Inhaler) in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)
Status: Enrolling
Updated:  10/23/2015
205.452.01011 Boehringer Ingelheim Investigational Site
mi
from
Clearwater, FL
Tiotropium + Olodaterol Fixed Dose Combination (FDC) in Chronic Obstructive Pulmonary Disease (OTEMTO 1)
A Randomised, Double-blind, Placebo- and Active-controlled Parallel Group Study to Assess the Efficacy of 12 Weeks of Once Daily Treatment of Two Doses of Orally Inhaled Tiotropium + Olodaterol Fixed Dose Combination (Delivered by the Respimat Inhaler) in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)
Status: Enrolling
Updated: 10/23/2015
205.452.01011 Boehringer Ingelheim Investigational Site
mi
from
Clearwater, FL
Click here to add this to my saved trials
Tiotropium + Olodaterol Fixed Dose Combination (FDC) in Chronic Obstructive Pulmonary Disease (OTEMTO 1)
A Randomised, Double-blind, Placebo- and Active-controlled Parallel Group Study to Assess the Efficacy of 12 Weeks of Once Daily Treatment of Two Doses of Orally Inhaled Tiotropium + Olodaterol Fixed Dose Combination (Delivered by the Respimat Inhaler) in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)
Status: Enrolling
Updated:  10/23/2015
205.452.01195 Boehringer Ingelheim Investigational Site
mi
from
Panama City, FL
Tiotropium + Olodaterol Fixed Dose Combination (FDC) in Chronic Obstructive Pulmonary Disease (OTEMTO 1)
A Randomised, Double-blind, Placebo- and Active-controlled Parallel Group Study to Assess the Efficacy of 12 Weeks of Once Daily Treatment of Two Doses of Orally Inhaled Tiotropium + Olodaterol Fixed Dose Combination (Delivered by the Respimat Inhaler) in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)
Status: Enrolling
Updated: 10/23/2015
205.452.01195 Boehringer Ingelheim Investigational Site
mi
from
Panama City, FL
Click here to add this to my saved trials
Tiotropium + Olodaterol Fixed Dose Combination (FDC) in Chronic Obstructive Pulmonary Disease (OTEMTO 1)
A Randomised, Double-blind, Placebo- and Active-controlled Parallel Group Study to Assess the Efficacy of 12 Weeks of Once Daily Treatment of Two Doses of Orally Inhaled Tiotropium + Olodaterol Fixed Dose Combination (Delivered by the Respimat Inhaler) in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)
Status: Enrolling
Updated:  10/23/2015
205.452.01059 Boehringer Ingelheim Investigational Site
mi
from
Coeur D'Alene, ID
Tiotropium + Olodaterol Fixed Dose Combination (FDC) in Chronic Obstructive Pulmonary Disease (OTEMTO 1)
A Randomised, Double-blind, Placebo- and Active-controlled Parallel Group Study to Assess the Efficacy of 12 Weeks of Once Daily Treatment of Two Doses of Orally Inhaled Tiotropium + Olodaterol Fixed Dose Combination (Delivered by the Respimat Inhaler) in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)
Status: Enrolling
Updated: 10/23/2015
205.452.01059 Boehringer Ingelheim Investigational Site
mi
from
Coeur D'Alene, ID
Click here to add this to my saved trials
Tiotropium + Olodaterol Fixed Dose Combination (FDC) in Chronic Obstructive Pulmonary Disease (OTEMTO 1)
A Randomised, Double-blind, Placebo- and Active-controlled Parallel Group Study to Assess the Efficacy of 12 Weeks of Once Daily Treatment of Two Doses of Orally Inhaled Tiotropium + Olodaterol Fixed Dose Combination (Delivered by the Respimat Inhaler) in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)
Status: Enrolling
Updated:  10/23/2015
205.452.01270 Boehringer Ingelheim Investigational Site
mi
from
Ann Arbor, MI
Tiotropium + Olodaterol Fixed Dose Combination (FDC) in Chronic Obstructive Pulmonary Disease (OTEMTO 1)
A Randomised, Double-blind, Placebo- and Active-controlled Parallel Group Study to Assess the Efficacy of 12 Weeks of Once Daily Treatment of Two Doses of Orally Inhaled Tiotropium + Olodaterol Fixed Dose Combination (Delivered by the Respimat Inhaler) in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)
Status: Enrolling
Updated: 10/23/2015
205.452.01270 Boehringer Ingelheim Investigational Site
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
Tiotropium + Olodaterol Fixed Dose Combination (FDC) in Chronic Obstructive Pulmonary Disease (OTEMTO 1)
A Randomised, Double-blind, Placebo- and Active-controlled Parallel Group Study to Assess the Efficacy of 12 Weeks of Once Daily Treatment of Two Doses of Orally Inhaled Tiotropium + Olodaterol Fixed Dose Combination (Delivered by the Respimat Inhaler) in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)
Status: Enrolling
Updated:  10/23/2015
205.440.1020 Boehringer Ingelheim Investigational Site
mi
from
Livonia, MI
Tiotropium + Olodaterol Fixed Dose Combination (FDC) in Chronic Obstructive Pulmonary Disease (OTEMTO 1)
A Randomised, Double-blind, Placebo- and Active-controlled Parallel Group Study to Assess the Efficacy of 12 Weeks of Once Daily Treatment of Two Doses of Orally Inhaled Tiotropium + Olodaterol Fixed Dose Combination (Delivered by the Respimat Inhaler) in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)
Status: Enrolling
Updated: 10/23/2015
205.440.1020 Boehringer Ingelheim Investigational Site
mi
from
Livonia, MI
Click here to add this to my saved trials
Tiotropium + Olodaterol Fixed Dose Combination (FDC) in Chronic Obstructive Pulmonary Disease (OTEMTO 1)
A Randomised, Double-blind, Placebo- and Active-controlled Parallel Group Study to Assess the Efficacy of 12 Weeks of Once Daily Treatment of Two Doses of Orally Inhaled Tiotropium + Olodaterol Fixed Dose Combination (Delivered by the Respimat Inhaler) in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)
Status: Enrolling
Updated:  10/23/2015
Boehringer Ingelheim Investigational Site
mi
from
Charlotte, NC
Tiotropium + Olodaterol Fixed Dose Combination (FDC) in Chronic Obstructive Pulmonary Disease (OTEMTO 1)
A Randomised, Double-blind, Placebo- and Active-controlled Parallel Group Study to Assess the Efficacy of 12 Weeks of Once Daily Treatment of Two Doses of Orally Inhaled Tiotropium + Olodaterol Fixed Dose Combination (Delivered by the Respimat Inhaler) in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)
Status: Enrolling
Updated: 10/23/2015
Boehringer Ingelheim Investigational Site
mi
from
Charlotte, NC
Click here to add this to my saved trials
Tiotropium + Olodaterol Fixed Dose Combination (FDC) in Chronic Obstructive Pulmonary Disease (OTEMTO 1)
A Randomised, Double-blind, Placebo- and Active-controlled Parallel Group Study to Assess the Efficacy of 12 Weeks of Once Daily Treatment of Two Doses of Orally Inhaled Tiotropium + Olodaterol Fixed Dose Combination (Delivered by the Respimat Inhaler) in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)
Status: Enrolling
Updated:  10/23/2015
Boehringer Ingelheim Investigational Site
mi
from
Cincinnati, OH
Tiotropium + Olodaterol Fixed Dose Combination (FDC) in Chronic Obstructive Pulmonary Disease (OTEMTO 1)
A Randomised, Double-blind, Placebo- and Active-controlled Parallel Group Study to Assess the Efficacy of 12 Weeks of Once Daily Treatment of Two Doses of Orally Inhaled Tiotropium + Olodaterol Fixed Dose Combination (Delivered by the Respimat Inhaler) in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)
Status: Enrolling
Updated: 10/23/2015
Boehringer Ingelheim Investigational Site
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Tiotropium + Olodaterol Fixed Dose Combination (FDC) in Chronic Obstructive Pulmonary Disease (OTEMTO 1)
A Randomised, Double-blind, Placebo- and Active-controlled Parallel Group Study to Assess the Efficacy of 12 Weeks of Once Daily Treatment of Two Doses of Orally Inhaled Tiotropium + Olodaterol Fixed Dose Combination (Delivered by the Respimat Inhaler) in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)
Status: Enrolling
Updated:  10/23/2015
1222.52.02029 Boehringer Ingelheim Investigational Site
mi
from
Columbia, OH
Tiotropium + Olodaterol Fixed Dose Combination (FDC) in Chronic Obstructive Pulmonary Disease (OTEMTO 1)
A Randomised, Double-blind, Placebo- and Active-controlled Parallel Group Study to Assess the Efficacy of 12 Weeks of Once Daily Treatment of Two Doses of Orally Inhaled Tiotropium + Olodaterol Fixed Dose Combination (Delivered by the Respimat Inhaler) in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)
Status: Enrolling
Updated: 10/23/2015
1222.52.02029 Boehringer Ingelheim Investigational Site
mi
from
Columbia, OH
Click here to add this to my saved trials
Tiotropium + Olodaterol Fixed Dose Combination (FDC) in Chronic Obstructive Pulmonary Disease (OTEMTO 1)
A Randomised, Double-blind, Placebo- and Active-controlled Parallel Group Study to Assess the Efficacy of 12 Weeks of Once Daily Treatment of Two Doses of Orally Inhaled Tiotropium + Olodaterol Fixed Dose Combination (Delivered by the Respimat Inhaler) in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)
Status: Enrolling
Updated:  10/23/2015
Boehringer Ingelheim Investigational Site
mi
from
Columbus, OH
Tiotropium + Olodaterol Fixed Dose Combination (FDC) in Chronic Obstructive Pulmonary Disease (OTEMTO 1)
A Randomised, Double-blind, Placebo- and Active-controlled Parallel Group Study to Assess the Efficacy of 12 Weeks of Once Daily Treatment of Two Doses of Orally Inhaled Tiotropium + Olodaterol Fixed Dose Combination (Delivered by the Respimat Inhaler) in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)
Status: Enrolling
Updated: 10/23/2015
Boehringer Ingelheim Investigational Site
mi
from
Columbus, OH
Click here to add this to my saved trials
Tiotropium + Olodaterol Fixed Dose Combination (FDC) in Chronic Obstructive Pulmonary Disease (OTEMTO 1)
A Randomised, Double-blind, Placebo- and Active-controlled Parallel Group Study to Assess the Efficacy of 12 Weeks of Once Daily Treatment of Two Doses of Orally Inhaled Tiotropium + Olodaterol Fixed Dose Combination (Delivered by the Respimat Inhaler) in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)
Status: Enrolling
Updated:  10/23/2015
1237.25.10511 Boehringer Ingelheim Investigational Site
mi
from
Dublin, OH
Tiotropium + Olodaterol Fixed Dose Combination (FDC) in Chronic Obstructive Pulmonary Disease (OTEMTO 1)
A Randomised, Double-blind, Placebo- and Active-controlled Parallel Group Study to Assess the Efficacy of 12 Weeks of Once Daily Treatment of Two Doses of Orally Inhaled Tiotropium + Olodaterol Fixed Dose Combination (Delivered by the Respimat Inhaler) in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)
Status: Enrolling
Updated: 10/23/2015
1237.25.10511 Boehringer Ingelheim Investigational Site
mi
from
Dublin, OH
Click here to add this to my saved trials